We establish innovative immunological approaches for the development of new therapies for dementia.
Welcome to Linuslifescience
We detect early biomarker signals from the peripheral immune system of patients suffering from neurodegenerative diseases such as Alzheimer’s dementia. Our goal is to develop novel therapies for these diseases through innovative immunological approaches.
After many failed therapeutic approaches, immunological correlations are increasingly becoming the focus of recent research, including the hypothesis that progressive neurodegenerative processes leading to dementia are the result of age-related inflammation.
We work closely with leading clinicians in neurology, neurobiology, and immunology. With our expertise, we are building a bridge from the diagnostic basics and the monitoring of biomarkers to the development of new therapies.
“Satisfaction of one’s curiosity is one of the greatest sources of happiness in life.”
LINUS PAULING (1901–1994)
The American chemist is considered to be the founder of “quantum chemistry.” As a committed scientist, he placed the complexity of the human body at the center of his work. He was awarded the Nobel Prize in 1954 for his research into the molecular structure of proteins and the Nobel Peace Prize in 1962 for his great commitment against nuclear weapon tests. He taught at the California Institute of Technology and Stanford University. In 1973, he founded the Linus Pauling Institute of Science and Medicine in Palo Alto, California.